Given the rapid progression of hearing loss that has been described for several DFNA9 mutations, these calculated ages of onset may be essential to determine the optimal moment of starting a (genetic) therapeutic intervention that aims to delay or stop progression of hearing loss. Here, COCH is linked to hearing loss disorder.